Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free SDCCQ Stock Alerts

SmileDirectClub (SDCCQ) Competitors

Compare

SDCCQ vs. GMVDF, VRAYQ, TTOO, AFIB, and SSKN

Should you buy SmileDirectClub stock or one of its competitors? MarketBeat compares SmileDirectClub with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SmileDirectClub include G Medical Innovations (GMVDF), ViewRay (VRAYQ), T2 Biosystems (TTOO), Acutus Medical (AFIB), and Strata Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry.

How does SmileDirectClub compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

G Medical Innovations has a beta of 28.55, indicating that its share price is 2,755% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
ViewRay Neutral
SmileDirectClub Neutral

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
SmileDirectClub N/A N/A N/A

ViewRay has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33M-$0.31N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

Summary

SmileDirectClub beats ViewRay on 5 of the 7 factors compared between the two stocks.

How does SmileDirectClub compare to T2 Biosystems?

SmileDirectClub (NASDAQ:SDCCQ) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

T2 Biosystems has lower revenue, but higher earnings than SmileDirectClub. T2 Biosystems is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

In the previous week, T2 Biosystems had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for SmileDirectClub. T2 Biosystems' average media sentiment score of 0.67 beat SmileDirectClub's score of 0.00 indicating that T2 Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
SmileDirectClub Neutral
T2 Biosystems Positive

SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.71, indicating that its stock price is 671% more volatile than the broader market.

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

T2 Biosystems beats SmileDirectClub on 6 of the 11 factors compared between the two stocks.

How does SmileDirectClub compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
SmileDirectClub N/A N/A N/A

Acutus Medical has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
SmileDirectClub Neutral

Acutus Medical has a beta of 5.67, suggesting that its share price is 467% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market.

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

SmileDirectClub beats Acutus Medical on 6 of the 10 factors compared between the two stocks.

How does SmileDirectClub compare to Strata Skin Sciences?

SmileDirectClub (NASDAQ:SDCCQ) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

SmileDirectClub has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SmileDirectClub's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Strata Skin Sciences Neutral

SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market.

Strata Skin Sciences has lower revenue, but higher earnings than SmileDirectClub. Strata Skin Sciences is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Given SmileDirectClub's higher probable upside, analysts plainly believe SmileDirectClub is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

SmileDirectClub beats Strata Skin Sciences on 9 of the 12 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

Export
MetricSmileDirectClubDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$40K$4.82M$6.86B$12.25B
Dividend YieldN/AN/A2.67%9.79%
P/E Ratio0.00N/A27.1423.64
Price / SalesN/A0.11517.0189.03
Price / CashN/AN/A50.5459.64
Price / BookN/A0.0110.286.07
Net Income-$86.40M-$60.92M$3.60B$331.99M

SmileDirectClub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
TTOO
T2 Biosystems
N/A$0.00
+200.0%		N/A-99.3%$13K$7.68MN/A180
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel